Conversely, in hepatocellular carcinomas [6], in pancreatic ductal adenocarcinomas [8,9], and in carcinomas of the biliary system [10], low PROX1 expression is associated with poor prognosis. This evidence concerns the gene PROX1 and hepatocellular carcinoma.